We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600031:SSESany Heavy Industry Co., Ltd. Class A Analysis

Data as of 2026-03-15 - not real-time

CN¥21.29

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Sany Heavy Industry (600031) trades at CNY 21.29, comfortably above its 20‑day SMA (22.77) and 50‑day SMA (22.35) but below the 200‑day SMA (20.88), indicating a short‑term pull‑back within a longer‑term uptrend. The RSI of 38.9 suggests the stock is nearing oversold territory, while the MACD remains bearish, hinting at possible downside pressure toward the near‑term support at CNY 20.83. Fundamentally, the company posted 10.5% revenue growth, a 9.6% profit margin, and a solid free cash flow of CNY 13.24 bn, supporting a sustainable dividend yield of 3.15% with a modest payout ratio of 37%. The DCF‑derived fair value of CNY 31.78 and a PE of 21.7 versus the industry average of 29.1 signal a clear undervaluation gap.
Recent material news highlights the successful Q3 2025 earnings beat and the strategic “A+H” dual‑listing on the Hong Kong exchange, expanding capital access and reinforcing the company’s global growth narrative. Combined with low‑to‑moderate beta, increasing volume, and a robust balance sheet (debt‑to‑equity 32.6%), the stock presents an attractive risk‑adjusted profile for investors seeking dividend income and upside potential.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Technical support at CNY 20.83 and bullish trend direction
  • Undervaluation relative to DCF fair value
  • Attractive dividend yield with sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of 10.5% and improving margins
  • Strategic dual‑listing expanding financing options
  • Potential price appreciation toward resistance at CNY 24.29

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term infrastructure demand in China and abroad
  • Strong free cash flow supporting dividend sustainability
  • Significant valuation gap between market price and DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth10.50%
Profit Margin9.57%
P/E Ratio21.7
ROE11.39%
ROA3.57%
Debt/Equity32.62
P/B Ratio2.4
Op. Cash FlowCN¥17.0B
Free Cash FlowCN¥13.2B
Industry P/E29.1

Technical Analysis

TrendBullish
RSI38.9
SupportCN¥20.83
ResistanceCN¥24.29
MA 20CN¥22.77
MA 50CN¥22.35
MA 200CN¥20.88
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueCN¥31.78
GradeUndervalued
TypeBlend
Dividend Yield3.15%

Risk Assessment

Beta0.01
Volatility38.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.